Omnes Capital — 2013 Investments
2 investments dated 2013 · listed companies and verified rows first · show all
Opsonaopsona.comSeries C · Oct 2013 · $4M
Co-investorsFountain Healthcare Partners
Tissiumtissium.com𝕏Series A · Dec 2013 · $11M
TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas.
BiotechDeep TechMedical DevicesNew Materials
Christophe Bancel(Co-founder & CEO)inMaria Pereira(Co-inventor of the technology; leads the Innovation Hub)in
Co-investorsCathay HealthKaristaSofinnova PartnersEuropean Investment Bank
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.